Showing results (31-40 of 71) with videos related to
Sort By:
Pageof 8
Anticancer Research|May 2, 2018
The Immune Checkpoint Molecule CD200 Is Associated with Tumor Grading and Metastasis in Bladder CancerPeter Rexin, Alessa Tauchert, Jörg Hänze, et al.Anticancer Research|August 28, 2004
Antineoplastic effect of immunostimulatory DNA (CpG-ODN) in a murine C57-BL6/MB-49 transitional cell carcinoma modelAxel Hegele, Alexander Dalpke, Peter Barth, et al.Urological Research|November 28, 2009
Efficacy and safety of the Accordion stone-trapping device: in vitro results from an artificial ureterolithotripsy modelPeter Jochen Olbert, Christian Keil, Jost Weber, et al.Journal of Cancer Research and Clinical Oncology|March 24, 2019
NOD1 and NOD2 of the innate immune system is differently expressed in human clear cell renal cell carcinoma, corresponding healthy renal tissue, its vasculature and primary isolated renal tubular epithelial cellsLilli Mey, Michaela Jung, Frederik Roos, et al.Anti-Cancer Drugs|August 31, 2006
Clinical significance of a prostate-specific antigen flare phenomenon in patients with hormone-refractory prostate cancer receiving docetaxelPeter Jochen Olbert, Axel Hegele, Petra Kraeuter, et al.Urologia Internationalis|July 31, 2009
Comparison of a 20-min pad test with the 1-hour pad test of the international continence society to evaluate post-prostatectomy incontinenceSandra Machold, Peter Jochen Olbert, Axel Hegele, et al.Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|April 29, 2016
Assessing blood platelets as RNA biomarker source for prostate cancerJörg Hänze, Peter Jakubowski, Hendrik Heers, et al.Urological Research|February 25, 2003
Cellular fibronectin in patients with transitional cell carcinoma of the bladderAxel Hegele, Axel Heidenreich, Zoltan Varga, et al.BMC Cancer|June 5, 2015
Vinflunine in routine clinical practice for the treatment of advanced or metastatic urothelial cell carcinoma - data from a prospective, multicenter experienceMargitta Retz, Patrick de Geeter, Peter J Goebell, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 14, 2004
Plasma levels of cellular fibronectin in patients with localized and metastatic renal cell carcinomaAxel Hegele, Axel Heidenreich, Jürgen Kropf, et al.Pageof 8